IL-17A is a proinflammatory cytokine which may be upregulated by fractalkine in T2D patients indirectly by the enhanced T cell infiltration and/or directly by the activation of Th17 cells in the adipose tissue. Here, CX3CL1 is linked to type 2 diabetes mellitus.